Eindhoven, Netherlands

Marc Stefan Robillard

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 4.7

ph-index = 6

Forward Citations = 102(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marc Stefan Robillard

Introduction

Marc Stefan Robillard is a prominent inventor based in Eindhoven, Netherlands. He has made significant contributions to the field of bio-orthogonal drug activation, holding a total of 13 patents. His work focuses on advancements in chemical cleavage and targeted therapeutics, showcasing his expertise in innovative drug delivery systems.

Latest Patents

Robillard's latest patents include a cleavable tetrazine used in bio-orthogonal drug activation. This invention provides a method for chemically cleaving a construct by utilizing a diene as a cleavable group. The process involves the reaction of the diene with a dienophile, which undergoes an inverse electron demand Diels-Alder reaction. Additionally, he has developed a prodrug activation method that employs abiotic reactive chemical groups exhibiting bio-orthogonal reactivity. This method is particularly relevant for antibody-drug conjugates and targeted therapeutics.

Career Highlights

Throughout his career, Robillard has worked with notable companies such as Tagworks Pharmaceuticals B.V. and Koninklijke Philips Corporation N.V. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in the pharmaceutical industry.

Collaborations

Robillard has collaborated with esteemed colleagues, including Ronny Mathieu Versteegen and Wolter Ten Hoeve. These partnerships have further enhanced his research and development efforts in the field of drug activation and delivery.

Conclusion

Marc Stefan Robillard's contributions to the field of bio-orthogonal drug activation and his extensive patent portfolio highlight his role as a leading inventor. His innovative approaches continue to influence the development of targeted therapeutics and drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…